Published in Br J Clin Pharmacol on November 01, 2003
Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol (2006) 1.49
Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs. Br J Clin Pharmacol (2005) 1.31
Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug Saf (2006) 1.12
Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children? Br J Clin Pharmacol (2005) 0.81
Inter-individual variation in midazolam clearance in children. Arch Dis Child (2014) 0.76
Inter-individual variation in morphine clearance in children. Eur J Clin Pharmacol (2015) 0.75
Paediatric pharmacokinetics and drug doses. Aust Prescr (2016) 0.75
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions. Biopharm Drug Dispos (2016) 0.75
Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ (2000) 8.10
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr (1999) 6.43
Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed (1999) 5.04
Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet (1996) 4.89
Testing medications in children. N Engl J Med (2002) 3.36
Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child (2002) 3.35
Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med (1960) 3.11
Reported adverse drug events in infants and children under 2 years of age. Pediatrics (2002) 3.00
Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol (2002) 2.41
Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child (2002) 2.17
Drug trials in children: problems and the way forward. Br J Clin Pharmacol (2000) 1.75
A novel scheme for the reporting of adverse drug reactions. Arch Dis Child (2001) 1.32
Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care. Br J Clin Pharmacol (2003) 1.25
Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth (2002) 1.25
Calculation of drug dosage and body surface area of children. Br J Anaesth (1997) 1.19
Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol (2003) 1.12
Medicines for children--the last century and the next. Arch Dis Child (2001) 1.10
Propranolol in the control of blood pressure: a dose-response study. Clin Pharmacol Ther (1980) 1.05
Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery. Br J Clin Pharmacol (2002) 0.96
Phenobarbital dosage for control of neonatal seizures. Neurology (1979) 0.91
Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis. Br J Anaesth (2002) 0.90
Inadequacy of FDA dosing guidelines for theophylline use in neonates. Drug Intell Clin Pharm (1986) 0.82
Diclofenac for acute pain in children. Cochrane Database Syst Rev (2009) 0.78
WITHDRAWN: Diclofenac for acute pain in children. Cochrane Database Syst Rev (2015) 0.75
The use of alum sludge to improve cereal production on a nutrient-deficient soil. Environ Technol (2013) 0.75